Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
Ciro Manzo,1 Maria Natale2 1Department of Geriatric and Internal Medicine, 2Geriatric Rheumatologic Outpatient Clinic, Hospital “Mariano Lauro,” Sant’Agnello, Naples, Italy Abstract: In the last few years, the relationship between polymyalgia rheumatica (PMR) and cancer...
Enregistré dans:
Auteurs principaux: | Manzo C, Natale M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/faaae872fea44a4898d132d4a742e043 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
par: Brawer AE
Publié: (2016) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
par: Hoon E, et autres
Publié: (2019) -
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
par: Ciro Manzo, et autres
Publié: (2021) -
Polymyalgia rheumatica following infective triggersor vaccinations: a different subset of disease?
par: Paolo Falsetti, et autres
Publié: (2020) -
Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
par: Ciro Manzo, et autres
Publié: (2020)